Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Other financing activities (2024)

Zentalis Pharmaceuticals has reported Other financing activities over the past 1 years, most recently at $241000.0 for Q1 2024.

  • Quarterly results put Other financing activities at $241000.0 for Q1 2024, changed N/A from a year ago — trailing twelve months through Sep 2024 was $241000.0 (changed N/A YoY), and the annual figure for FY2020 was $18.4 million, changed.
  • Other financing activities for Q1 2024 was $241000.0 at Zentalis Pharmaceuticals.
  • Over the last five years, Other financing activities for ZNTL hit a ceiling of $241000.0 in Q1 2024 and a floor of $241000.0 in Q1 2024.